A detailed history of Janus Henderson Group PLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 66,187 shares of IRWD stock, worth $285,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,187
Previous 66,187 -0.0%
Holding current value
$285,265
Previous $431,000 36.89%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.58 - $8.61 $4,408 - $6,801
-790 Reduced 1.18%
66,187 $431,000
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $33 - $61
4 Added 0.01%
66,977 $583,000
Q4 2023

Feb 14, 2024

SELL
$8.79 - $11.51 $962,636 - $1.26 Million
-109,515 Reduced 62.05%
66,973 $766,000
Q3 2023

Nov 14, 2023

SELL
$8.25 - $11.35 $2.98 Million - $4.1 Million
-361,617 Reduced 67.2%
176,488 $1.7 Million
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $4.76 Million - $5.46 Million
471,054 Added 702.53%
538,105 $5.73 Million
Q1 2023

May 15, 2023

BUY
$10.37 - $12.56 $448,450 - $543,157
43,245 Added 181.66%
67,051 $705,000
Q4 2022

Feb 14, 2023

SELL
$9.9 - $12.43 $19 - $24
-2 Reduced 0.01%
23,806 $294,000
Q3 2022

Nov 14, 2022

SELL
$10.14 - $12.38 $902 - $1,101
-89 Reduced 0.37%
23,808 $247,000
Q2 2022

Aug 15, 2022

SELL
$11.05 - $12.72 $78,421 - $90,273
-7,097 Reduced 22.9%
23,897 $276,000
Q1 2022

May 16, 2022

BUY
$10.61 - $12.88 $106 - $128
10 Added 0.03%
30,994 $390,000
Q4 2021

Feb 14, 2022

BUY
$10.86 - $13.95 $169,111 - $217,229
15,572 Added 101.04%
30,984 $361,000
Q3 2021

Nov 16, 2021

BUY
$11.92 - $13.92 $183,711 - $214,535
15,412 New
15,412 $201,000
Q4 2020

Feb 16, 2021

SELL
$9.05 - $12.2 $30.6 Million - $41.3 Million
-3,386,302 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.99 - $10.74 $90,996 - $108,710
10,122 Added 0.3%
3,386,302 $30.5 Million
Q2 2020

Aug 14, 2020

SELL
$9.14 - $11.97 $35.1 Million - $46 Million
-3,840,044 Reduced 53.21%
3,376,180 $34.8 Million
Q1 2020

May 14, 2020

SELL
$8.58 - $14.01 $9.21 Million - $15 Million
-1,073,671 Reduced 12.95%
7,216,224 $72.8 Million
Q4 2019

Feb 18, 2020

BUY
$8.22 - $14.0 $7.31 Million - $12.4 Million
888,863 Added 12.01%
8,289,895 $110 Million
Q3 2019

Nov 14, 2019

SELL
$8.59 - $10.96 $895,601 - $1.14 Million
-104,261 Reduced 1.39%
7,401,032 $63.6 Million
Q2 2019

Jul 31, 2019

BUY
$9.8 - $12.89 $8.35 Million - $11 Million
852,356 Added 12.81%
7,505,293 $82.1 Million
Q1 2019

Apr 30, 2019

SELL
$8.27 - $12.73 $15,456 - $23,792
-1,869 Reduced 0.03%
6,652,937 $90 Million
Q4 2018

Feb 06, 2019

SELL
$7.8 - $16.13 $10.4 Million - $21.5 Million
-1,331,969 Reduced 16.68%
6,654,806 $68.9 Million
Q3 2018

Nov 09, 2018

SELL
$14.31 - $17.65 $1.16 Million - $1.43 Million
-81,163 Reduced 1.01%
7,986,775 $147 Million
Q2 2018

Aug 10, 2018

SELL
$11.83 - $16.2 $702,110 - $961,470
-59,350 Reduced 0.73%
8,067,938 $154 Million
Q1 2018

May 14, 2018

SELL
$11.13 - $13.63 $2.03 Million - $2.49 Million
-182,350 Reduced 2.19%
8,127,288 $125 Million
Q4 2017

Feb 09, 2018

BUY
$12.16 - $14.58 $4.46 Million - $5.34 Million
366,483 Added 4.61%
8,309,638 $125 Million
Q3 2017

Nov 14, 2017

SELL
$12.07 - $14.87 $315,546 - $388,746
-26,143 Reduced 0.33%
7,943,155 $0
Q2 2017

Aug 17, 2017

BUY
N/A
7,969,298
7,969,298 $150 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $660M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.